Home » Topics » Regulatory

Regulatory
RSS

Abbott receives FDA approval for HIV-1/HIV-2 blood screening test

Sep. 25, 2009

Sabril launched in U.S. for patients with difficult-to-treat epilepsy

Sep. 25, 2009

FDA approves Valturna, a single-pill combination of aliskiren and valsartan

Sep. 18, 2009

Theravance and Astellas obtain FDA approval of Vibativ

Sep. 16, 2009

Lumavita is granted marketing authorization in Switzerland for pentamycin for vaginitis

Sep. 1, 2009

FDA approves Embeda for moderate to severe chronic pain

Aug. 17, 2009

Saphris approved by FDA for schizophrenia and bipolar I disorder

Aug. 17, 2009

Invega approved for the treatment of schizoaffective disorder

Aug. 6, 2009

Invega Sustenna approved for acute and maintenance schizophrenia treatment

Aug. 5, 2009

FDA approves AstraZeneca and Bristol-Myers' Onglyza for type 2 diabetes

Aug. 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...